Susquehanna Fundamental Investments, LLC Karuna Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$101.2 - $125.87 $593,740 - $738,479
-5,867 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$75.23 - $109.23 $1.02 Million - $1.49 Million
-13,600 Reduced 69.86%
5,867 $596,000
Q3 2020

Nov 16, 2020
BUY
$71.31 - $109.74 $518,209 - $797,480
7,267 Added 59.57%
19,467 $1.51 Million
Q2 2020

Aug 14, 2020
BUY
$62.14 - $117.21 $758,108 - $1.43 Million
12,200 New
12,200 $1.36 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email